FDA Biologics (BLA & Biosimilars)Original article
Expedited IND Pilot Program Educational Webinar for Stakeholders - 08/06/2026
Neutral
AI Analysis
Summary
FDA conducted an educational webinar on August 6, 2026, to introduce stakeholders to a proposed Expedited Investigational New Drug (IND) pilot program designed to accelerate the timeline from drug identification to first-in-human clinical trials.
Importance:2/10
Sentiment:
0.00
FDAINDExpedited ProgramEducational WebinarClinical Trials
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on August 10, 2026 2:56 PM